Clinical Trials

• P1060:  Phase II, parallel, randomized, clinical trials comparing the responses to initiation of

  Study Location: India

  Eligibility: HIV-infected infants and children ≥ 2 months to < 36 months of age who are eligible for ART as defined by the WHO...

  Enrollment:

  Read More

• P1073: Study of Immune Reconstitution Inflammatory Syndrome (IRIS) for International Sites

  Study Location: India

  Eligibility: Ages Eligible for Study:  up to 72 Months   (Child) Sexes Eligible for Study:  All Accepts Healthy Volunteers:...

  Enrollment:

  Read More

• P1077BF: Breastfeeding Version of the PROMISE Study (Promoting Maternal and Infant Survival

  Study Location: India

  Eligibility: Antepartum component - Pregnant HIV-infected women who intend to breastfeed and their infants. Late Presenters - Late...

  Enrollment:

  Read More

• P1077FF: Formula Feeding Version of the PROMISE Study (Promoting Maternal and Infant Survival

  Study Location: India

  Eligibility: Antepartum Component – HIV-infected pregnant women who intend to formula feed (FF) (with and without HBV) with documented...

  Enrollment: Closed

  Read More

• P1078: A Phase IV Randomized Double-Blind Placebo-Controlled Trial to Evaluate the Safety of

  Study Location: India

  Eligibility: Mother/infant pairs: HIV-infected pregnant women ≥ 14 weeks through ≤ 34 weeks (34 weeks, 6 days) gestation.

  Enrollment:

  Read More
• ‹ First  < 3 4 5